It is made from a leukocyte fraction obtained from the patient’s peripheral blood, which is cultured with an antigen specific to prostate carcinoma, known as prostatic acid phosphatase (PAP), in the presence of GM-CSF [55]. This evidence concerns the gene ACP3 and prostate carcinoma.